ATE208818T1 - Knochenwachstumsfördernder faktor - Google Patents

Knochenwachstumsfördernder faktor

Info

Publication number
ATE208818T1
ATE208818T1 AT94908917T AT94908917T ATE208818T1 AT E208818 T1 ATE208818 T1 AT E208818T1 AT 94908917 T AT94908917 T AT 94908917T AT 94908917 T AT94908917 T AT 94908917T AT E208818 T1 ATE208818 T1 AT E208818T1
Authority
AT
Austria
Prior art keywords
gly
polypeptide
lys
ala
pro
Prior art date
Application number
AT94908917T
Other languages
English (en)
Inventor
Cherk Shing Tam
Original Assignee
Osteopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osteopharm Inc filed Critical Osteopharm Inc
Application granted granted Critical
Publication of ATE208818T1 publication Critical patent/ATE208818T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94908917T 1993-03-12 1994-03-14 Knochenwachstumsfördernder faktor ATE208818T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3138693A 1993-03-12 1993-03-12
US12021793A 1993-09-13 1993-09-13
PCT/CA1994/000144 WO1994020615A1 (en) 1993-03-12 1994-03-14 Bone stimulating factor

Publications (1)

Publication Number Publication Date
ATE208818T1 true ATE208818T1 (de) 2001-11-15

Family

ID=26707172

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94908917T ATE208818T1 (de) 1993-03-12 1994-03-14 Knochenwachstumsfördernder faktor

Country Status (19)

Country Link
EP (1) EP0688360B1 (de)
JP (1) JP3733381B2 (de)
KR (1) KR960701201A (de)
CN (1) CN1119457A (de)
AT (1) ATE208818T1 (de)
AU (1) AU678441B2 (de)
BR (1) BR9406447A (de)
CA (1) CA2157901A1 (de)
CZ (1) CZ234295A3 (de)
DE (1) DE69429082T2 (de)
ES (1) ES2168295T3 (de)
FI (1) FI954252A0 (de)
HU (1) HUT73297A (de)
IL (1) IL108947A0 (de)
NO (1) NO953286L (de)
NZ (1) NZ262352A (de)
PL (1) PL182236B1 (de)
TW (1) TW385314B (de)
WO (1) WO1994020615A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786327A (en) 1993-03-12 1998-07-28 Gensci Regeneration Sciences Inc. Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same
US5880094A (en) * 1995-06-07 1999-03-09 Osteopharm Limited Polypeptides that stimulate bone growth
US6352973B1 (en) 1995-06-07 2002-03-05 Osteopharm Inc. Bone stimulating factor
US6117839A (en) * 1995-06-07 2000-09-12 Gensci Regeneration Sciences, Inc. Bone stimulating factor
US6693081B2 (en) 1995-09-26 2004-02-17 Osteopharm Inc. Bone stimulating factor
ES2320603T3 (es) 1997-07-30 2009-05-25 Emory University Sistemas de expresion, vectores, adn, proteinas de mineralizacion osea novedosos.
EP1015565B1 (de) 1997-09-19 2006-04-12 Metabolix, Inc. Biologische systeme zur herstellung von polyhydroxyalkanoate polymeren die 4-hydroxysäure enthalten
DE19906096A1 (de) 1999-02-13 2000-08-17 Walter Sebald Protein mit einem Heparin-bindenden Epitop
WO2000075185A1 (en) * 1999-06-02 2000-12-14 Osteopharm Inc. Bone stimulating factor
MXPA02002251A (es) 1999-08-30 2003-08-20 Interleukin Genetics Inc Diagnosticos y terapeuticos para osteoporosis.
US6815421B1 (en) 2001-03-22 2004-11-09 Osteopharm Inc. Polypeptides for use in ameliorating effects of aging in mammals
CA2534365A1 (en) 2003-08-08 2005-02-17 Interleukin Genetics, Inc. Diagnostic and therapeutics for osteoporosis
DE602007008147D1 (de) * 2006-12-21 2010-09-09 Numat As Konsensus-peptid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0128041A3 (de) * 1983-06-06 1986-12-03 David Jeston Baylink Polypeptide mit einer Skelettwachstumsfaktor-Wirksamkeit
CA2020729A1 (en) * 1989-07-19 1991-01-20 Michael C. Kiefer Bone morphogenetic protein

Also Published As

Publication number Publication date
DE69429082D1 (de) 2001-12-20
BR9406447A (pt) 1996-02-13
HU9502659D0 (en) 1995-11-28
FI954252A7 (fi) 1995-09-11
KR960701201A (ko) 1996-02-24
JP3733381B2 (ja) 2006-01-11
CZ234295A3 (en) 1996-04-17
DE69429082T2 (de) 2002-07-25
CN1119457A (zh) 1996-03-27
CA2157901A1 (en) 1994-09-15
NO953286L (no) 1995-10-25
PL182236B1 (pl) 2001-11-30
AU678441B2 (en) 1997-05-29
EP0688360A1 (de) 1995-12-27
FI954252A0 (fi) 1995-09-11
JPH08508158A (ja) 1996-09-03
ES2168295T3 (es) 2002-06-16
IL108947A0 (en) 1994-06-24
HUT73297A (en) 1996-07-29
AU6179794A (en) 1994-09-26
NZ262352A (en) 1997-10-24
PL310617A1 (en) 1995-12-27
EP0688360B1 (de) 2001-11-14
WO1994020615A1 (en) 1994-09-15
NO953286D0 (no) 1995-08-22
TW385314B (en) 2000-03-21

Similar Documents

Publication Publication Date Title
Gregory et al. The primary structure of human urogastrone
Weber et al. Maturation of nuclear lamin A involves a specific carboxy-terminal trimming, which removes the polyisoprenylation site from the precursor; implications for the structure of the nuclear lamina
ATE208818T1 (de) Knochenwachstumsfördernder faktor
EP2145897A3 (de) Therapeutische Verfahren und Zusammensetzungen basierend auf Serrate-Proteinen und Nukleinsäuren
EP1053255A4 (de) DREIDIMENSIONALE STRUKTUREN UND MODELLE VON Fc-REZEPTOREN UND IHRE VERWENDUNGEN.
CA2000893C (en) Biologically active lipoprotein and its use
AU5963290A (en) Inhibition of the n-end rule pathway in living cells
IE57880B1 (en) Novel atrial peptide
DE3486154D1 (de) Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung.
ATE162201T1 (de) Cnp-gen und vorläuferprotein aus schwein
KR940005669A (ko) 사이클로펩타이드, 및 점막에 적용시 흡수 촉진제로서의 이의 용도
KR980002066A (ko) 변이형 인간 성장호르몬 및 그의 용도
EP0357067A3 (de) Rekombinanter natürlicher Killerzellen-Aktivator
US5814610A (en) Osteogenic growth oligopeptides and pharmaceutical compositions containing them
Piétu et al. Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries
JPS646219A (en) Peptide having promoting action on activation of protein c by thrombin
Sluss et al. Inhibition of iodine-125-labeled human follitropin binding to testicular receptor by epidermal growth factor and synthetic peptides
EP0292257A3 (de) Peptide mit ANF-Wirksamkeit
RU2001127439A (ru) Пептиды из последовательности Т-вируса и моноспецифические антитела, связывающиеся с ТТ-вирусом
CA2163212A1 (en) Therapeutic compounds
RU96118231A (ru) Биотиновые производные, способ их получения, фармацевтические композиции и способ их получения
FERRARA et al. β‐Endorphin: Interaction of synthetic analogs having different chain lengths with morphine and enkephalin receptors in rat brain membranes
FR2691153B1 (fr) Dodecapeptides monomere et dimere, utilisation en tant qu'agents anti-megacaryocytaires.
JP2796835B2 (ja) ヒトカルパスタチン様ポリペプチド
Monet et al. In vitro relative biological activities of (1--34) N-terminal synthetic fragments of human parathyroid hormone in the human renal cortical adenylate cyclase assay

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties